Exploration of Pregnant Women's Reluctance Toward COVID-19 Vaccination

NCT06968117 | Completed

• 1 other identifier: 0025_MATERNITE
• Study Type: observational
• Target: 15
• Locations: 1 country
• Sites: 1

Brief Summary

This study aims to explore the reasons behind the reluctance of pregnant women to get vaccinated against COVID-19. With the ongoing pandemic, it has become essential to understand the concerns that women have regarding the COVID-19 vaccine, especially during pregnancy. Pregnant women are at a higher risk of severe complications from COVID-19, including premature birth, preeclampsia, and the need for intensive care.The goal of this research is to identify the barriers that prevent pregnant women from getting vaccinated, whether they are based on fears, misconceptions, or a lack of information. By understanding these concerns, healthcare providers can have better conversations with their patients and provide accurate, evidence-based information to help them make informed decisions about their health and the health of their unborn child.Through interviews and visual methods, the study seeks to gather valuable insights into the emotional and psychological aspects of vaccine hesitancy among pregnant women. These findings will help develop a tool to assist healthcare providers in addressing vaccine hesitancy effectively, ensuring that women are given all the necessary information to make the best decision for their health and the well-being of their baby.

Conditions

Vaccinate Against Covid-19; Reluctance Pregnant Women's

Outcome Measures

Primary Outcomes (1)

• The rate of vaccine hesitancy among pregnant women, assessed through a standardized questionnaire.

  January 2021-April 2023

Study Arms (1)

Pregnant women participating in the study on COVID-19 vaccination hesitancy.

This group consists of pregnant women, recruited during prenatal consultations, hospital admissions, or visits to obstetric emergencies. The aim is to explore their perceptions and hesitations regarding COVID-19 vaccination.

Eligibility Criteria

• Age: 18 Years+
• Sex: female
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

The study participants will be selected from pregnant women attending pregnancy follow-up consultations, those who have visited the Gynecology-Obstetrics emergency department for any reason, and those hospitalized in the diabetes or high-risk pregnancy (GHR) departments or in postpartum care services. Participants must be over 18 years old and able to provide informed consent.

You may qualify if:

• During pregnancy follow-up consultations,
• Following their visit to the Gynecology-Obstetrics emergency department, regardless of the reason,
• Hospitalized in the diabetology department or in the high-risk pregnancy (HRP) or postpartum care department.

You may not qualify if:

• The patient is over 18 years old

Sponsors & Collaborators

• Centre Hospitalier de Gonesse: lead

Study Sites (1)

France

Gonesse, France

Location

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: May 12, 2025
• First Posted: May 13, 2025
• Study Start: November 1, 2021
• Primary Completion: January 1, 2023
• Study Completion: January 1, 2023
• Last Updated: May 13, 2025

Record last verified: 2025-05

Locations

FR (1)